09:08 AM EDT, 09/19/2025 (MT Newswires) -- Emergent BioSolutions ( EBS ) said Friday it has secured $29 million in purchase orders from an international government partner.
The orders cover medical countermeasures for smallpox, anthrax and botulism threats, the company said.
Under the deal, Emergent BioSolutions ( EBS ) said it will receive about $26 million in 2025.